Monte Rosa Therapeutics, Inc
Monte Rosa Therapeutics is seeking a B-Cell Biologist for a 6-month contract in Boston to support the development and characterization of novel molecular glue degraders for autoimmune and inflammatory diseases. The role involves designing and executing experiments using primary immune cells and tissues, and characterizing target mechanisms of action through various immuno-assays. The ideal candidate will collaborate with the Discovery Immunology team to advance multiple I&I projects from early discovery through lead optimization.
Monte Rosa Therapeutics is a biotechnology company pioneering molecular glue degrader (MGD) therapies that promote specific protein ubiquitination and subsequent proteasomal degradation of disease-causing, traditionally undruggable proteins. Their drug discovery platform integrates expertise in MGD chemistry, artificial intelligence, structural biology, and proteomics to rapidly advance programs targeting undruggable or inadequately drugged targets with unprecedented specificity. Focused on cancer and beyond, the company operates out of Boston, MA and Basel, Switzerland.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc didn’t post a salary, so this is our estimate from similar listings.
26% below the average for this role
Principal Biologist
Eli Lilly and Company
Pharma Discovery Molecular Biologist
Cogent Scientific
Associate Scientist/ Senior associate Scientist
Gilead Sciences
Cell Biologist and Assay Developer
Abiologics
Research Associate, Immuno-Oncology Research
Moderna
Scientist / Senior Scientist, Bioanalytical Sciences
Addition Therapeutics